Evaluating the Impact of Reining in Anxiety
1 other identifier
interventional
78
1 country
1
Brief Summary
The purpose of this pilot study is to evaluate the impact of Reining in Anxiety for children with anxiety and their caregivers. A total of up to 80 child/caregiver dyads will be enrolled in the study, anticipating that 40 dyads will complete the 10 week intervention. The intervention will be delivered at Fieldstone Farm Therapeutic Riding Center, which is one of the largest therapeutic riding centers in the US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable anxiety
Started Feb 2021
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2021
CompletedFirst Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedFebruary 10, 2022
February 1, 2022
6 months
March 23, 2021
February 8, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Change in levels of Anxiety
This will be measured by the Generalized Anxiety Disorder-2 (GAD-2) questionnaire which consists of two items that assesses the presence of anxiety. Items are summed, and a score of 3 or higher is usually indicative of further evaluation.
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Change in the Psychological functioning
The Children's Global Assessment Scale (CGAS). The child is given a single score between 1- 100, based on an assessment of a range of aspects related to the child's psychological and social functioning. The score places them in one of ten categories, ranging from "extremely impaired" (1-10) to "doing very well (91-100).
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Secondary Outcomes (8)
Change in children's emotional regulation
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Change in parents' perception of children's emotional regulation
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Change in emotional self efficacy
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Change in the level of knowledge of anxiety
Before Session 1 (baseline) , After Session 10 ( after 6 months)
Traumatic events of children
Before Session 1 (baseline)
- +3 more secondary outcomes
Study Arms (1)
Treatment Group
EXPERIMENTALA total of up to 80 child/caregiver dyads will be enrolled in the study, anticipating that 40 dyads will complete the 10 week intervention. An equine assisted therapy called Reining in Anxiety for children with anxiety and their caregivers.
Interventions
This equine assisted therapy (EAT), which is delivered in a group setting, combines therapeutic horseback riding with cognitive behavioral strategies for anxiety. Each 45 minute session is delivered in a group format with up to four children between 6 and 17 years of age. Each session follows the same structure: (1) weekly review; (2) groom and connect; (3) warm-up period; (4) session activity; (5) cool down; (6) parent/caregiver psychoeducation, during which the instructor facilitates psychoeducation; and (7) homework instruction.
Eligibility Criteria
You may qualify if:
- Caregiver/child dyads where the children are between six and 17 years of age and their caregivers will be enrolled in the study.
- Children must have a score of 3 or higher as measured by the GAD-2,
- Children must have a minimum level of functioning as measured by the CGAS of 41 or higher.
You may not qualify if:
- An inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly Hoagwood, PhD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2021
First Posted
April 1, 2021
Study Start
February 22, 2021
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
February 10, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share
Pilot study data only